
Bevacizumab: New Option for Breast Cancer REFERENCE: 5th European Breast Cancer Conference, Nice, 21st – 25th March 2006 Robin Zon, Michiana Hematology Oncology, South Bend, Indiana Bevacizumab
Bevacizumab: New Option for Breast Cancer

REFERENCE: 5th European Breast Cancer Conference, Nice, 21st – 25th March 2006Robin Zon, Michiana Hematology Oncology, South Bend, IndianaBevacizumab could be a new treatment option in metastatic breast cancer, according to a study reported at the 5th European Breast Cancer conference in Nice. Derek Thorne spoke to Robin Zon of Michiana Hematology Oncology, in South Bend Indiana, about the study findings.
Radiation for Young Patients with Prostate Cancer?

REFERENCE: Cancer, 2006, May 8André Konski, Fox Chase Cancer Center, PhiladelphiaDoes age matter when selecting a treatment for patients with early stage prostate cancer? A study reported in the journal Cancer suggests it may not. André Konski told Derek Thorne about a retrospective study carried out at the Fox Chase Cancer Center in Philadelphia.
Better Combine Chemotherapy with Radiation for Hodgkins’ Disease

REFERENCE: Journal of Clinical Oncology 2006; 24:605Bridget Koontz, Duke University Medical Center, DurhamIn early stage Hodgkin’s Disease many doctors are now using combined modality therapy, involving chemotherapy and a lower dose of radiation. Bus is it any safer than radiation alone? A retrospective study from Duke University Medical Center suggests that it is. Derek Thorne got the details from Bridget Koontz.
Tags
Related Episodes

Audio Journal of Medicine
In this edition: 1. Training In Depression And Suicide: Need For Change? Stan Kutcher, Dalhousie University, Nova Scotia 2. Suicide Paradox Explained: Australian National Strategy Barry Nurcombe, Prin

Audio Journal of Oncology Volume 16 Number 9
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam Angel Rod

Virus Plus Cytokine Fight Primary and Metastatic Cancer
Paul Fisher REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles PAUL FISHER, Columbia University, New York Patients with cancer could soon be treated with adenoviruses capable of infecting b